InvestorsHub Logo
Followers 5
Posts 359
Boards Moderated 0
Alias Born 01/10/2019

Re: Amatuer17 post# 42732

Wednesday, 06/26/2019 10:02:46 AM

Wednesday, June 26, 2019 10:02:46 AM

Post# of 233763
It's not that they want to immediately initiate a Phase 2 study in NASH if the pre-clinical results are positive - it's simply a means to further enhance the value of the company, while only spending a couple of thousand dollars. An option for NASH in Phase 2 adds a lot of value, especially since the future of NASH treatments seems to lie in a combo approach - Leronlimab, being extremely safe, is ideal for a combo treatment, e.g. with Genfits or Galectin's molecules.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News